ONESOURCE SPECIALTY PHARMA
|
The Current P/S Ratio of ONESOURCE SPECIALTY PHARMA is 10.77.
| Share Price | ₹1,580.8 | Nov 04,2026 |
| Market Cap | ₹18,131.2 Cr | |
| Sales-TTM | ₹1,683.8 Cr | TTM-Consolidated Results |
| Price/Sales | 10.77x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of ONESOURCE SPECIALTY PHARMA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹18,131.2 Cr] as on Nov 04,2026
(/) Sales [ ₹1,683.8 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 10.77x ]
Thus, for ONESOURCE SPECIALTY PHARMA , the investors are currently willing to pay '10.77 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of ONESOURCE SPECIALTY PHARMA !
The chart below summarizes the trend in P/S Ratio of ONESOURCE SPECIALTY PHARMA over the last five years.
Historical PS (Price/Sales) ratio chart of ONESOURCE SPECIALTY PHARMA
PS Ratio Performance Analysis for ONESOURCE SPECIALTY PHARMA
- ONESOURCE SPECIALTY PHARMA 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 5.14x.
- ONESOURCE SPECIALTY PHARMA 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ONESOURCE SPECIALTY PHARMA 's p/e ratio peaked in Mar2025 at 13.84x.
- ONESOURCE SPECIALTY PHARMA 's p/e ratio hit its five-year low in Mar2024 of 0x.
How does ONESOURCE SPECIALTY PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| ONESOURCE SPECIALTY PHARMA | 1,683.8 | 10.77 | 18,131.2 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 61,630.9 | 6.91 | 426,122.0 |
| DIVIS LABORATORIES LTD | 11,230.0 | 23.72 | 266,424.0 |
| TORRENT PHARMACEUTICALS LTD | 17,400.0 | 10.34 | 179,914.0 |
| CIPLA LTD | 28,138.9 | 4.02 | 113,112.0 |
| DR REDDYS LABORATORIES LTD | 33,097.4 | 3.46 | 114,599.0 |
| MANKIND PHARMA LTD | 15,378.6 | 6.80 | 104,631.0 |
| LUPIN LTD | 30,746.3 | 3.00 | 92,144.5 |
| ZYDUS LIFESCIENCES LTD | 30,378.1 | 3.91 | 118,703.0 |
| AUROBINDO PHARMA LTD | 34,935.3 | 2.80 | 97,877.5 |
| LAURUS LABS LTD | 7,822.5 | 15.93 | 124,601.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs ONESOURCE SPECIALTY PHARMA 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.80x |
| Max industry PS | 23.72x |
| Median industry PS | 6.80x |
| Average industry PS | 8.33x |
You may also like the below Video Courses